Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLESENCE, INC. Director's Dealing 2022

Jun 8, 2022

33563_dirs_2022-06-08_92ab6a6f-398c-47e6-b665-4cfe7cd185a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2022-06-06

Reporting Person: JANKOWSKI JESS (Director, President, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-06 Common Stock M 11455 $0.30 Acquired 70455 Direct
2022-06-06 Common Stock S 11455 $3.03 Disposed 59000 Direct
2022-06-07 Common Stock M 100 $0.30 Acquired 59100 Direct
2022-06-07 Common Stock S 100 $3.00 Disposed 59000 Direct
2022-06-08 Common Stock M 1500 $0.30 Acquired 60500 Direct
2022-06-08 Common Stock S 1500 $3.00 Disposed 59000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-06-06 Common Stock (right to purchase) $0.30 M 11455 Disposed 2022-08-07 Common Stock (11455) Direct
2022-06-07 Common Stock (right to purchase) $0.30 M 100 Disposed 2022-08-07 Common Stock (100) Direct
2022-06-08 Common Stock (right to purchase) $0.30 M 1500 Disposed 2022-08-07 Common Stock (86445) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1000 Indirect
Common Stock 59000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Common Stock (right to purchase) $0.415 2023-02-14 Common Stock (90000) 90000 Direct
Common Stock (right to purchase) $0.52 2024-02-13 Common Stock (90000) 90000 Direct
Common Stock (right to purchase) $0.44 2025-02-18 Common Stock (81000) 81000 Direct
Common Stock (right to purchase) $0.42 2026-02-23 Common Stock (69000) 69000 Direct
Common Stock (right to purchase) $0.68 2027-02-21 Common Stock (81000) 81000 Direct
Common Stock (right to purchase) $0.82 2028-05-23 Common Stock (90000) 90000 Direct
Common Stock (right to purchase) $0.51 2029-05-22 Common Stock (16500) 16500 Direct
Common Stock (right to purchase) $0.45 2027-06-18 Common Stock (90000) 90000 Direct
Common Stock (right to purchase) $4.17 2028-12-28 Common Stock (90000) 90000 Direct

Footnotes

F1: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

F3: Subject to certain restrictions, beginning on this date, options vest in three equal installments.

F4: Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.